Results from a Phase III registrational study suggest that ecopipam has potential as a first-in-class dopamine-1 receptor ...

The Phase III DIAMOND trial met both its primary and secondary endpoints of reducing tics in both children and adult patients ...

Ecopipam showed statistical significance in treating Tourette syndrome versus a placebo for both its primary efficacy ...

Emalex Biosciences met primary and secondary endpoints in its Phase 3 registrational trial of ecopipam for patients with ...

In the Phase III trial, 41.9% of pediatric Tourette syndrome patients relapsed after ecopipam treatment, as compared with ...

Emalex Biosciences’ dopamine blocker led to fewer patients with Tourette syndrome relapsing in a phase 3 trial, setting the ...

Baylen Out Loud star Baylen Dupree has considered undergoing deep brain stimulation as a treatment for her symptoms of ...

Chicago, USA-based Emalex Biosciences announced positive top-line data from its Phase III registrational study of ecopipam, a ...

TikToker Baylen Dupree, who shares her life with Tourette Syndrome on social media, announced her engagement to Colin Dooley ...

TLC will continue to follow Baylen Dupree’s journey as she navigates life with Tourette Syndrome as the network renewed ...

Since Baylen Out Loud premiered on TLC in January 2025, Tourette syndrome advocate Baylen Dupree has gained even more social ...

Baylen Dupree was interviewed on the 'Not Skinny But Not Fat' podcast on Feb. 19 and revealed she doesn't get tics when she's ...